Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches: A Concordance Study with IHC Assessment

E. Ruszova, Z. Khaznadar, Z. Spurkova, K. Vlcanova

. 2025 ; 26 (5) : . [pub] 20250227

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009791

Grantová podpora
Charles University

The immunohistochemical (IHC) or fluorescence/chromogenic in situ hybridization (FISH/CISH) assays for assessing HER2 are now recommended by the American Society of Clinical Oncologists and the College of American Pathologists, but there are an increasing number of published studies describing alternative diagnoses at the molecular level. Inspired by these studies, we established a laboratory-developed test (LDT) to analyze HER2 status not only at the gene expression level but also at the gene copy number. A precise copy number calculation was fulfilled including the Control Genomic DNA of known concentration, which allowed subsequent assay validation at the DNA level. The results were reported according to the concordant results of the DNA and RNA approaches. By comparing with IHC determination, completely identical results were found in ten blank samples, which underlines the legitimacy of molecular biological approaches in this diagnostic field. An equivocal sample that was positive by IHC and qPCR was found to be negative by the FISH and so it may change the choice of personalized medicine. The topic of this short communication will hopefully contribute to allowing IVD-certified diagnostics based on the HER2 gene expression profile or copy number to be tested in the Czech Republic as well.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009791
003      
CZ-PrNML
005      
20250429135214.0
007      
ta
008      
250415s2025 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms26052148 $2 doi
035    __
$a (PubMed)40076767
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Ruszova, Ema $u Laboratory of Clinical Genetics, University Hospital Bulovka, 180 81 Prague, Czech Republic $1 https://orcid.org/0000000314276625
245    10
$a Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches: A Concordance Study with IHC Assessment / $c E. Ruszova, Z. Khaznadar, Z. Spurkova, K. Vlcanova
520    9_
$a The immunohistochemical (IHC) or fluorescence/chromogenic in situ hybridization (FISH/CISH) assays for assessing HER2 are now recommended by the American Society of Clinical Oncologists and the College of American Pathologists, but there are an increasing number of published studies describing alternative diagnoses at the molecular level. Inspired by these studies, we established a laboratory-developed test (LDT) to analyze HER2 status not only at the gene expression level but also at the gene copy number. A precise copy number calculation was fulfilled including the Control Genomic DNA of known concentration, which allowed subsequent assay validation at the DNA level. The results were reported according to the concordant results of the DNA and RNA approaches. By comparing with IHC determination, completely identical results were found in ten blank samples, which underlines the legitimacy of molecular biological approaches in this diagnostic field. An equivocal sample that was positive by IHC and qPCR was found to be negative by the FISH and so it may change the choice of personalized medicine. The topic of this short communication will hopefully contribute to allowing IVD-certified diagnostics based on the HER2 gene expression profile or copy number to be tested in the Czech Republic as well.
650    _2
$a lidé $7 D006801
650    12
$a receptor erbB-2 $x genetika $x metabolismus $7 D018719
650    12
$a imunohistochemie $x metody $7 D007150
650    12
$a hybridizace in situ fluorescenční $x metody $7 D017404
650    12
$a genová dávka $7 D018628
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nádory prsu $x genetika $x metabolismus $x diagnóza $7 D001943
650    _2
$a RNA $x metabolismus $x genetika $x analýza $7 D012313
650    _2
$a DNA $x genetika $x metabolismus $7 D004247
650    _2
$a nádorové biomarkery $x genetika $x metabolismus $7 D014408
655    _2
$a časopisecké články $7 D016428
700    1_
$a Khaznadar, Ziad $u The Central Laboratories, University Hospital Bulovka, 180 81 Prague, Czech Republic $u Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic
700    1_
$a Spurkova, Zuzana $u Department of Anatomical Pathology, University Hospital Bulovka, 180 81 Prague, Czech Republic
700    1_
$a Vlcanova, Katerina $u Laboratory of Clinical Genetics, University Hospital Bulovka, 180 81 Prague, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 26, č. 5 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40076767 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135210 $b ABA008
999    __
$a ok $b bmc $g 2311277 $s 1246872
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 26 $c 5 $e 20250227 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$p Charles University
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace